Sensex ends at day's low, down 746 pts ; Bajaj Auto jumps 11%; RIL down 2%

Shares of Reliance Industries ended 2.4 per cent lower on Friday ahead of the announcement of its December quarter results. The shares have surged around 6 per cent during the week

SI Reporter New Delhi

Sensex ends at day's low, down 746 pts ; Bajaj Auto jumps 11%; RIL down 2%

11:12 AM

ALERT :: Selling pressure intensifies on Sensex

11:05 AM

NEWS ALERT :: Alembic Pharma gets US FDA approval for Midodrine Hydrochloride Tablets

>> It is used for treatment of symptomatic orthostatic hypotension

10:56 AM

1 million new investors entering the market on a monthly basis, shows data

Mansi Majithia has just begun the process of signing up to invest in the stock market. She’d invested earlier, but the amounts were small. This will be her first serious foray into equities.

And, it comes even as the market has touched an all-time high. She is not alone in putting her money in the stock market. There are around one million new investors entering the market on a monthly basis, shows regulatory data READ MORE

10:45 AM

BUZZING STOCK:: Bajaj Auto extends gain

10:38 AM

YES Bank slips ahead of Q3 numbers later today

10:28 AM

Biocon tanks 10% on lower-than-expected December quarter results

Shares of Biocon plunged 10 per cent to Rs 400 on the BSE in the morning deals on Friday after the company posted below par December quarter (Q3FY21) results, with consolidated net profit down 17 per cent year on year (YoY) at Rs 169 crore. Ebitda (earnings before interest, taxes, depreciation, and amortization) declined 10.1 per cent YoY to Rs 400 crore, while Ebitda margins contracted 383 basis points YoY to 21.6 per cent mainly due to higher employee, R&D and other expenditure. READ MORE

10:15 AM

Kajaria Ceramics extends rally to 4th day, rises 5%

In Q3FY21, Kajaria Ceramics reported 93 per cent year on year (YoY) jump in its consolidated net profit at Rs 118.94 crore as against a Rs 61.54-crore profit in Q3FY20. The company’s Ebitda (earnings before interest, taxes, depreciation, and amortization) margins expanded to 21.68 per cent from 15.02 per cent in the year-ago quarter.

10:11 AM

SECTOR WATCH:: Auto stocks in focus

Company	LATEST(rs)	CHG(%)
Tata Motors	304.25	4.75
Ashok Leyland	124.40	4.06
Tata Motors-DVR	115.90	5.32
Bajaj Auto	3933.00	6.11
Eicher Motors	3012.80	2.93

» More

10:02 AM

Rupee Opening

Rupee opens lower at 73.03 per US dollar vs Thursday's close of 72.99/$

9:58 AM

JK Tyre zooms 51% in 4 days, hits fresh 52-week high on robust Q3 results

Shares of JK Tyre & Industries hit a fresh 52-week high of Rs 132, soaring 14 per cent on the BSE in the early morning trade on Friday, after the company reported highest-ever quarterly sales and net profit for the quarter ended December 2020 (Q3FY21). The stock of tyre & rubber products maker zoomed 51 per cent in past four trading days. READ MORE

9:50 AM

Most active stocks by volume

Company	PRICE(rs)	CHG(%)	VOLUME
Vodafone Idea	12.90	0.16	8253306
Future Consumer	8.95	4.56	3938316
Tata Motors	305.15	5.06	3214036
South Ind.Bank	8.46	-6.73	2408899
Bharat Electron	134.75	0.75	1385290

» More on Most Active Volume

9:49 AM

MARKET VIEW | V K Vijayakumar, Chief Investment Strategist at Geojit Financial Services

This has been a 'Buy on Dips' market for months now. Sustained FII buying has been the main catalyst behind this strategy. Of late, better than expected corporate results have been supporting this strategy. Nothing warrants a change in this strategy now. But the market is likely to move into a consolidation phase for the short-term since the big news regarding the US presidency is behind us and the milestone of 50000 Sensex was reached. A positive surprise is the continuous flow of excellent corporate results. This will take away some concerns regarding valuations. Sustained FII inflows (Rs 1615 cr yesterday) can deter the bears from going short.

9:43 AM

Result impact :: Biocon plunges over 8%

>> Biopharmaceutical major Biocon posted a nearly 19 per cent dip on YoY basis in its consolidated net profit at Rs 186.6 crore for the third quarter of financial year 2020-21, owing to its generics business taking a hit along with headwinds across operational, regulatory and commercial functions.